Briefing Summary: US FDA Posts Advisory Committee Materials for Translarna by PTC Therapeutics for Nonsense Mutation Dystrophinopathy Report
Briefing Summary: US FDA Posts Advisory Committee Materials for Translarna by PTC Therapeutics for Nonsense Mutation Dystrophinopathy Report